Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis

List of reports from Roots Analysis

< prev 1    3  4  
Cell Therapy Manufacturing Market, 2017-2027
3/3/2017 | published by: Roots Analysis
... practice has now become an integral part of clinical procedures in the space of bone marrow regeneration and organ transplantation. Cell-based therapies are an emerging segment of the overall biopharmaceutical industry. Post the approval of ...  |  read more...
USD 2,499
T-Cell Immunotherapy Market (2nd Edition), 2017-2030
1/31/2017 | published by: Roots Analysis
... growing segments of the pharmaceutical industry. Harnessing immune system components for developing therapeutic solutions has demonstrated significant clinical benefit for various diseases areas, specifically against a number of oncological indications. Immunotherapeutics have gradually gained a ...  |  read more...
USD 2,499
Large Volume Wearable Injectors Market (3rd Edition), 2017-2027
1/31/2017 | published by: Roots Analysis
... therapeutic regimen have become the preferred choice of drug administration. The large scale adoption of prefilled syringes, the first ready-to-use injection device to be marketed, demonstrated the growing interest in the concept of such convenient ...  |  read more...
USD 2,499
Prefilled Syringes Market (4th Edition), 2016 - 2026
12/8/2016 | published by: Roots Analysis
... devices have become preferred devices for parenteral administration of drugs. Specifically, the demand for prefilled syringes has been rising strongly over the past several years. A growing number of healthcare facilities are now adopting this ...  |  read more...
USD 2,349
Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016 - 2026
11/18/2016 | published by: Roots Analysis
... is characterized by pain and swelling in and around the joints. It is a systemic disease and is known to affect several joints at the same time or different joints at different times. Hence, it ...  |  read more...
USD 2,349
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming
11/17/2016 | published by: Roots Analysis
... are also used for prophylactic purposes in patients who have undergone surgery, or immunocompromised patients (cancer patients undergoing chemotherapy). However, the inappropriate use of antibiotics, both in healthcare and food production, has rapidly accelerated an ...  |  read more...
USD 2,349
Ubiquitin Enzymes: Key Targets and Future Market Potential, 2016-2030
10/24/2016 | published by: Roots Analysis
... regulation of several cellular processes. The UPS consists of two separate consecutive steps, ubiquitination and proteasomal degradation. Due to its involvement in multiple metabolic and regulatory functions, the UPS is considered as a vital part ...  |  read more...
USD 2,349
PDE Inhibitors Market, 2016-2026
10/20/2016 | published by: Roots Analysis
... phosphodiesterases (PDEs) and the establishment of their role in diseases led to the development of drugs targeting this class of enzymes. PDEs are a complex superfamily of metallophosphohydrolase enzymes that regulate the activity of second ...  |  read more...
USD 2,349
Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026
10/19/2016 | published by: Roots Analysis
... viral infections. Gene therapies and genetically modified therapies involve the introduction of therapeutic DNA (gene of interest) into the patient’s body. There have been a number of successful trials in several systems showing the efficient ...  |  read more...
USD 2,349
Dendritic Cell and Tumor Cell Cancer Vaccines Market, 2016-2030
9/30/2016 | published by: Roots Analysis
... relapse. In 2016, an estimated 1.7 million new cancer cases were reported in the US alone. Furthermore, as projected by the World Health Organization (WHO), the annual incidence of cancer worldwide is expected to rise ...  |  read more...
USD 2,349
Smart Wearables in Healthcare, 2016-2030
9/8/2016 | published by: Roots Analysis
... ever increasing global population that currently stands at 7.4 billion, healthcare management is a primary challenge as more and more people become aware about fitness and health. In order to address this challenge, the industry ...  |  read more...
USD 2,349
Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026
8/26/2016 | published by: Roots Analysis
... in intraocular pressure (IOP). Acutely elevated IOP, a condition broadly known as ocular hypertension, may either lead to the expulsion of ocular contents through a traumatic opening or result in a number of clinical conditions ...  |  read more...
USD 2,349
HDAC Inhibitors Market, 2016 - 2026
8/19/2016 | published by: Roots Analysis
... can be modulated primarily include histone modification, DNA methylation, alteration of chromatin architecture and involvement of small-interfering or non-coding RNAs. Enzymes such as histone acetyltransferases (HATs), histone methyltransferases (HMTs), histone deacetylases (HDACs) and histone demethylases ...  |  read more...
USD 2,349
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026
8/11/2016 | published by: Roots Analysis
... the US. The increasing incidence, growing prevalence and the progressive nature of the disease has spurred several pharmaceutical companies to develop novel approaches / therapies to provide better treatment options for diabetic patients worldwide. While ...  |  read more...
USD 2,349
Immune Checkpoint Inhibitors: Clinical Trial Tracker
7/21/2016 | published by: Roots Analysis
... checkpoints are molecules that regulate (stimulate or inactivate) the immune cells. Yervoy (an anti CTLA-4 inhibitor) was the first immune checkpoint inhibitor that was made commercially available in 2011 for treatment of patients suffering from ...  |  read more...
USD 949
T-cell Immunotherapy: Clinical Trial Tracker
7/11/2016 | published by: Roots Analysis
... promising therapeutic strategies, developed under the banner of T-cell immunotherapies, are set to hit the market in the near future. T-cells, also named as the soldiers of the immune system, are featured with specificity and ...  |  read more...
USD 949
Vaccine Contract Manufacturing Market, 2016 - 2026
6/29/2016 | published by: Roots Analysis
... standards, have limited competition among vaccine manufacturers. In addition, these complexities have also restricted innovation in this space to a great extent. However, recent advances in biotechnology and biomanufacturing have resulted in the development of ...  |  read more...
USD 2,349
Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026
6/15/2016 | published by: Roots Analysis
... that help in the diagnosis, treatment and monitoring of therapeutic agents. The discovery of several nanocarriers such as polymers, proteins, micelles, dendrimers, liposomes, emulsions, nanoparticles, each with a unique structure, has provided the drug developers ...  |  read more...
USD 2,349
DNA Repair Drugs: Focus on PARP Inhibitors, 2016-2026
5/23/2016 | published by: Roots Analysis
... However, DNA is not inert. Cells are continuously exposed to several endogenous and exogenous insults that often cause DNA damage. Despite its role in cellular signalling, ROS, a by-product of mitochondrial respiration, is known to ...  |  read more...
USD 2,349
Global Autoinjectors Market, 2016 - 2026
5/11/2016 | published by: Roots Analysis
... to conventional delivery systems, these devices automate the process of delivering drugs through subcutaneous or intramuscular routes. Autoinjectors are primarily spring-driven systems and use fillable / prefilled syringes or cartridges as primary containers. Due to ...  |  read more...
USD 2,349
Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026
3/31/2016 | published by: Roots Analysis
... The Y-arm of the antibody is known as Fab, comprising a constant and a variable domain from each light and heavy chain. The variable domain (Fv) within the Fab region is responsible for target specificity ...  |  read more...
USD 2,199
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026
3/9/2016 | published by: Roots Analysis
... the key focus of researchers and manufacturers worldwide. HPAPIs, which include cytotoxic APIs, are drug substances that are formulated to manufacture high potency drug products. Cytotoxic drugs are a category of highly potent drug products ...  |  read more...
USD 2,199
Speciality CROs Market, 2016-2025
2/11/2016 | published by: Roots Analysis
... overcome the shortcomings of full service / traditional CROs. Often, these full service providers offer a wider portfolio of services but fail to align their efforts to meet the requirements of sponsors, primarily the smaller ...  |  read more...
USD 2,199
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025
2/8/2016 | published by: Roots Analysis
... smaller in size and can be easily synthesized, optimized and evaluated as viable therapeutic solutions for a number of diseases. These highly favourable and intrinsic characteristics of peptides have caused an evident shift in the ...  |  read more...
USD 2,199
< prev 1    3  4  
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!